Results 241 to 250 of about 314,800 (327)
ABSTRACT Nemolizumab, an anti‐interleukin‐31 receptor A monoclonal antibody, has been approved in Japan for treating atopic dermatitis (AD)‐associated pruritus. While it is effective for itch control, nemolizumab‐associated cutaneous adverse events have been increasingly recognized, yet their clinical features remain poorly characterized. In this study,
Wataru Sasaki +24 more
wiley +1 more source
Treatment of a mandibular molar with primary failure of eruption: A case report. [PDF]
Guo M, Zhang W.
europepmc +1 more source
ABSTRACT Atopic dermatitis (AD) is a chronic inflammatory disease characterized by recurrent remissions and relapses. Topical anti‐inflammatory steroids are commonly used for treatment, but their long‐term use poses concerns because of potential side effects. Delgocitinib ointment, a Janus kinase inhibitor, has demonstrated efficacy in several clinical
Masatoshi Abe +5 more
wiley +1 more source
Reactive Infectious Mucocutaneous Eruption Following Isolated Rhinovirus Infection: Clinical Presentation and Treatment Response. [PDF]
Verma KK +7 more
europepmc +1 more source
ABSTRACT Accurate diagnosis is essential for timely intervention in atopic dermatitis (AD), yet delays in diagnosis remain common. To better understand current clinical practices regarding infantile AD, a questionnaire survey was conducted among Japanese pediatricians working at medical institutions with 19 or fewer beds.
Kiwako Yamamoto‐Hanada +6 more
wiley +1 more source
Record phenological responses to climate change in three sympatric penguin species
This paper is impressive because we managed to monitor extensively a really difficult place to reach and operate in. We deployed 77 cameras across Antarctica and the Sub Antarctic islands to monitor three different species of penguins. We found that they are the fastest advancing vertebrates with respect to their timing of breeding.
Ignacio Juarez Martinez +8 more
wiley +1 more source

